Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $6.0950 (0.91%) ($6.0950 - $6.0950) on Tue. Oct. 12, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.24% (three month average) | RSI | 45 | Latest Price | $6.0950(0.91%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1% a day on average for past five trading days. | Weekly Trend | CGEN advances 0.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(71%) ARKG(69%) ARKK(67%) IWO(65%) IBUY(64%) | Factors Impacting CGEN price | CGEN will decline at least -1.62% in a week (0% probabilities). VIXM(-52%) VXX(-37%) UUP(-13%) TLT(-7%) SHY(-2%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.62% (StdDev 3.24%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
Resistance Level | $6.2 | 5 Day Moving Average | $6.24(-2.32%) | 10 Day Moving Average | $6.16(-1.06%) | 20 Day Moving Average | $6.2(-1.69%) | To recent high | -19.9% | To recent low | 4.9% | Market Cap | $504m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |